Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 92,448,158
- Total 13F shares
- 8,314,673
- Share change
- +8,314,673
- Total reported value
- $164,045,000
- Price per share
- $19.73
- Number of holders
- 28
- Value change
- +$164,044,999
- Number of buys
- 28
Quarterly Holders Quick Answers
What is CUSIP 92511W108?
CUSIP 92511W108 identifies VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2018
Recent filing periods for CUSIP 92511W108:
Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2018
As of 30 Jun 2018,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,314,673 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, FMR LLC, Fosun International Ltd, FIL Ltd, GILDER GAGNON HOWE & CO LLC, KORNITZER CAPITAL MANAGEMENT INC /KS, CONNING INC., SPHERA FUNDS MANAGEMENT LTD., and Monashee Investment Management LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2018 holders
28
Holder diff
27
| Investor | Q3 2025 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.